NIH hopes to win over skeptics with drug repurposing successes

07/18/2013 | Nature (free content)

Nine awardees will split $12.7 million from the NIH to find new targets for eight abandoned drug compounds. Critics say the National Center for Advancing Translational Sciences program has low odds of succeeding because drugmakers that developed the compounds abandoned them for a reason. Proponents say even moderate success will yield substantial return on the investment.

View Full Article in:

Nature (free content)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD